Fig. 4
Probability of events of hypoglycemia with incretin-based agents versus placebo. Effect of incretin-based agents on any (a) and severe (b) hypoglycemia was analyzed individually. CI confidence interval, DPP-4I dipeptidyl peptidase-4 inhibitor, GLP-1A glucagon-like peptide-1 agonist